Business Context and Reporting Period
This Form 8-K is a current report filed by Landec Corporation (not Lifecore Biomedical, Inc., as indicated in the metadata) on July 19, 2017. The filing addresses Item 5.02 regarding compensatory arrangements for certain officers.
Key Financial Metrics
The filing does not provide specific financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity figures. It solely describes the methodology for a future incentive plan.
Material Changes
The Board of Directors approved a new Long-Term Incentive Plan (LTIP) for fiscal year 2020. This plan introduces cash bonuses for participating employees, including named executive officers Molly Hemmeter, Gregory Skinner, and Ronald Midyett.
Guidance, Outlook, and Management Commentary
- Incentive Structure: Bonuses are based on the Company's Return on Invested Capital (ROIC) for fiscal year 2020.
- ROIC Calculation: Defined as consolidated Earnings Before Interest and Taxes (EBIT) divided by the sum of average consolidated debt plus average stockholders' equity for fiscal year 2020.
- Payout Formula: Bonuses equal the individual target amount multiplied by the percentage of the target ROIC achieved.
- Target Amounts: Individual targets range from 18% to 62% of base salaries.
- Eligibility: Employees must remain employed through the last day of fiscal year 2020 to receive the bonus.
Investor Verification Checklist
- Verify the specific target ROIC percentage required to trigger bonus payments, as the filing does not state the numerical target.
- Confirm the exact base salaries of the named executive officers to calculate potential bonus exposure.
- Review the Company's fiscal year 2020 definition to ensure alignment with the incentive period.
- Check subsequent filings for any amendments to the LTIP or changes in executive compensation.